• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Adaptive immunity in cancer immunology and therapeutics. 
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Molecular Oncology
    • Adaptive immunity in cancer immunology and therapeutics.
    •   QMRO Home
    • Barts Cancer Institute
    • Centre for Molecular Oncology
    • Adaptive immunity in cancer immunology and therapeutics.
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Adaptive immunity in cancer immunology and therapeutics.

    View/Open
    Published version (351.6Kb)
    Volume
    8
    Pagination
    441 - ?
    DOI
    10.3332/ecancer.2014.441
    Journal
    Ecancermedicalscience
    ISSN
    1754-6605
    Metadata
    Show full item record
    Abstract
    The vast genetic alterations characteristic of tumours produce a number of tumour antigens that enable the immune system to differentiate tumour cells from normal cells. Counter to this, tumour cells have developed mechanisms by which to evade host immunity in their constant quest for growth and survival. Tumour-associated antigens (TAAs) are one of the fundamental triggers of the immune response. They are important because they activate, via major histocompatibility complex (MHC), the T cell response, an important line of defense against tumourigenesis. However, the persistence of tumours despite host immunity implies that tumour cells develop immune avoidance. An example of this is the up-regulation of inhibitory immune checkpoint proteins, by tumours, which induces a form of self-tolerance. The majority of monoclonal antibodies in clinical practice have been developed to target tumour-specific antigens. More recently there has been research in the down-regulation of immune checkpoint proteins as a way of increasing anti-tumour immunity.
    Authors
    Spurrell, EL; Lockley, M
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/6573
    Collections
    • Centre for Molecular Oncology [256]
    Language
    eng
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.